These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23850368)

  • 1. Dental management considerations for a patient taking dabigatran etexilate: a case report.
    Romond KK; Miller CS; Henry RG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e191-5. PubMed ID: 23850368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D; Taylor M
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C; Robertson C; Shivakumar S; Lee M
    J Can Dent Assoc; 2013; 79():d74. PubMed ID: 23920075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct oral thrombin inhibitor, "dabigatran"].
    Yasaka M
    Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
    Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C
    Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran for anticoagulation in atrial fibrillation - early clinical experience in a hospital population and comparison to trial data.
    Michel J; Mundell D; Boga T; Sasse A
    Heart Lung Circ; 2013 Jan; 22(1):50-5. PubMed ID: 23058974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
    Chevalier J; Giroud M; de Pouvourville G
    Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ; Wallentin L; Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Pogue J; Alings M; Amerena JV; Avezum A; Baumgartner I; Budaj AJ; Chen JH; Dans AL; Darius H; Di Pasquale G; Ferreira J; Flaker GC; Flather MD; Franzosi MG; Golitsyn SP; Halon DA; Heidbuchel H; Hohnloser SH; Huber K; Jansky P; Kamensky G; Keltai M; Kim SS; Lau CP; Le Heuzey JY; Lewis BS; Liu L; Nanas J; Omar R; Pais P; Pedersen KE; Piegas LS; Raev D; Smith PJ; Talajic M; Tan RS; Tanomsup S; Toivonen L; Vinereanu D; Xavier D; Zhu J; Wang SQ; Duffy CO; Themeles E; Yusuf S
    Circulation; 2013 Jul; 128(3):237-43. PubMed ID: 23770747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between dabigatran concentration, as assessed using the direct thrombin inhibitor assay, and activated clotting time/activated partial thromboplastin time in patients with atrial fibrillation.
    Okubo K; Kuwahara T; Takagi K; Takigawa M; Nakajima J; Watari Y; Nakashima E; Yamao K; Fujino T; Tsutsui H; Takahashi A
    Am J Cardiol; 2015 Jun; 115(12):1696-9. PubMed ID: 25918026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH; Diener HC
    Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dabigatran-induced acute hepatitis.
    Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dabigatran, a new oral anticoagulant].
    Uchiyama S
    Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired renal function and bleeding in elderly treated with dabigatran.
    Berthelot E; Lavenu-Bombled C; Orostegui-Giron L; Desconclois C; Assayag P
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):618-20. PubMed ID: 24509332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.
    Husari A; Beydoun A; Sheik Ammar A; Maakaron JE; Taher A
    J Thromb Thrombolysis; 2013 Jan; 35(1):81-2. PubMed ID: 22843168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran in clinical practice--one-year experience at Skåne University Hospital.
    Bergman E; Smith JG; Wieloch M; Braun OÖ; Svensson P; van der Pals J
    Thromb Res; 2013 Aug; 132(2):316-7. PubMed ID: 23664182
    [No Abstract]   [Full Text] [Related]  

  • 17. New oral anticoagulants in atrial fibrillation forever?
    Verheugt FW
    Circulation; 2013 Jul; 128(3):200-2. PubMed ID: 23770746
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    Firriolo FJ; Hupp WS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):431-41. PubMed ID: 22668425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of dabigatran-associated acute renal failure.
    Shafi ST; Negrete H; Roy P; Julius CJ; Sarac E
    WMJ; 2013 Aug; 112(4):173-5; quiz 176. PubMed ID: 24734407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C; George J; Levine R
    N Z Med J; 2013 Mar; 126(1370):110-2. PubMed ID: 23474519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.